p38 MAP kinase: Essential role in hypoxia-mediated human pulmonary artery fibroblast proliferation

Pulmonary Pharmacology and Therapeutics

Volumn 20, Issue 6, 2007, Pages 718-725

  Mortimer, Heather J ^a   Peacock, Andrew J ^a   Kirk, Alan ^a   Welsh, David J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Hypoxia; Molecular biology; Pulmonary hypertension; Remodelling

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; HYPOXIA INDUCIBLE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE P38; THYMIDINE;

ARTICLE; CELL GROWTH; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CIRCULATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PULMONARY ARTERY; SYSTEMIC CIRCULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL HYPOXIA; CELL PROLIFERATION; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAMMARY ARTERIES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PULMONARY ARTERY; THYMIDINE;

EID: 34548820973     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2006.08.007     Document Type: Article

References (27)

1. D'Alonzo G.E., Barst R.J., Ayres S.M., Bergofsky E.H., Brundage B.H., Detre K.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115 5 (1991) 343-349
2. Morrell N.W., Sarybaev A.S., Alikhan A., Mirrakhimov M.M., and Aldashev A.A. Ace genotype and risk of high altitude pulmonary hypertension in Kyrghyz highlanders. The Lancet 353 (1999) 814
3. Aldashev A.A., Sarybaev A.S., Sydykov A.S., Kalmyrzaev B.B., Kim E.V., Mamanova L.B., et al. Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin-converting enzyme genotype. Am J Respir Crit Care Med 166 10 (2002) 1396-1402
4. Meyrick B., and Reid L. Hypoxia and the incorporation of 3H-thymidine by cells of the rat pulmonary arteries and alveolar wall. Am J Pathol 96 1 (1979) 51-69
5. Meyrick B., and Reid L. Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am J Pathol 100 1 (1980) 151-169
6. Raeside D.A., Brown A., Patel K.R., Welsh D., and Peacock A.J. Ambulatory pulmonary artery pressure monitoring during sleep and exercise in normal individulas and pateints with COPD. Thorax 57 12 (2002) 1050-1053
7. Euler U.S.V., and Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Phys Scandinavica 12 (1946) 301-320
8. Wagner E.M., and Mitzner W.A. Effect of hypoxia on bronchial circulation. Am J Physiol 65 4 (1988) 1627-1633
9. Welsh D.J., Scott P., Plevin R., Wadsworth R., and Peacock A.J. Hypoxia enhances cellular proliferation and inositol 1,4,5-triphosphate generation in fibroblasts from bovine pulmonary artery but not from mesenteric artery. Am J Respir Crit Care Med 158 (1998) 1757-1762
10. Welsh D.J., Peacock A.J., MacClean M., and Harnett M. Chronic hypoxia induces constitutive p38 mitogen-activated protein kinase activity that correlated with enhanced cellular proliferation in fibroblasts from rat pulmonary but not systemic arteries. Am J Respir Crit Care Med 164 (2001) 282-289
11. Scott P.H., Paul A., Belham C.M., Peacock A.J., Wadsworth R.M., Gould G.W., et al. Hypoxic stimulation of the stress-activated protein kinases in pulmonary artery fibroblasts. Am J Crit Care Med 158 (1998) 958-962
12. Sutter C.H., Laughner E., and Semenza G.L. Hypoxia-inducbile factor 1 alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. PNAS 97 74748-53 (2000)
13. Freshney, I.R., 1983. Culture of animal cells. New York: A.R. Liss.
14. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., et al. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin 1. FEBS Lett 364 (1995) 229
15. Das M., Bouschey D.M., Moore M.J., Hopkins D.C., Nemenoff R.A., and Stenmark K.R. Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on g protein-medicated activation of mitogen-activated protein kinases. J Biol Chem 276 19 (2001) 15631-15640
16. Das M., Dempsey E.C., Bouchey D., Reyland M.E., and Stenmark K.R. Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: potential contribution of specific protein kinase C isozymes. Am J Respir Cell Mol Biol 22 (2000) 15-25
17. Krick S., Hanze J., Eul B., Savai R., Seay U., Grimminger F., et al. Hypoxia-driven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF-1 alpha and an autocrine angiotensis system. FASEB J 19 (2005) 857-859
18. Welsh D.J., Scott P.H., and Peacock A.J. p38 MAP kinase isoform activity and cell cycle regulators in the proliferative response of pulmonary and systemic artery fibroblasts to acute hypoxia. Pulm Pharm Therapeut 19 (2006) 128-138
19. Semenza G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor-1. Ann Rev Cell Dev Biol 15 (1999) 551-578
20. See F., Thomas W., Way K., Tzanidis A., Kompa A., Lewis D., et al. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infartion in the rat. J Am Coll Cardiol 44 (2004) 1679-1689
21. Mandal S.K., Rao L.V.M., Tran T.T.T., and Pendurthi U.R. A novel mechanism of plasmin-induced mitogenisis in fibroblasts. J Thromb Haemost 3 (2005) 163-169
22. Wang J.G., Miyazu M., Xiang P., Li S.N., Sokabe M., and Naruse K. Stretch-induced cell proliferation is mediated by FAK-MAPK pathway. Life Sci 76 (2005) 2817-2825
23. Seto H., Kamekura S., Miura T., Yamamoto A., Chikuda H., Ogata T., et al. Distinct roles of Smad pathways and p38 pathways in cartilage-specific gene expression in synovial fibroblasts. J Clin Invest 113 (2004) 718-726
24. Furukawa F., Matsuzaki K., Mori S., Tahashi Y., Yoshida K., Sugano Y., et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 38 (2003) 879-889
25. Abecassis L., Rogier E., Vazquez A., Atfi A., and Bourgeade M.F. Evidence for a role of MSK1 in transformimg growth factor-β-mediated responses through p38α and Smad signaling pathways. J Biol Chem 279 (2004) 30474-30479
26. English J.M., and Cobb M.H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 23 1 (2002) 40-45
27. Kumar S., Boehm J., and Lee J.C. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2 9 (2003) 717-726